Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsNobuaki Ito, Hirofumi Sasaki, Kuninori Tai, Tomoichi Shinohara
Life of this patent
Estimating the term…